This product does not require an MSDS and we do not have MSDS to offer.
Please use this email as confirmation. We have datasheets and technical
information available online through www.scbt.com. Please let me know
if you need further assistance.
Bcl-2 (N-19) is recommended for detection of Bcl-2 of mouse, rat and
human origin by Western Blotting (starting dilution 1:200, dilution range
1:100-1:1000), immunoprecipitation [1–2 µg per 100–500 µg of total protein
(1 ml of cell lysate)], immunofluorescence and immunohistochemistry
(including paraffin-embedded sections) (starting dilution 1:50, dilution
Suitable for use as control antibody for Bcl-2 siRNA (h): sc-29214 and Bcl-2
siRNA (m): sc-29215.
SELECT PRODUCT CITATIONS
1. McKean, D.J., et al. 2001. Maturation Versus Death of Developing
Double-Positive Thymocytes Reflects Competing Effects on Bcl-2
Expression and Can Be Regulated by the Intensity of CD28 Costimulation.
J. Immunol. 166: 3468-3475.
2. Aoki, Y., et al. 2003 . Inhibition of STAT3 signaling induces apoptosis and
decreases survivin expression in primary effusion lymphoma. Blood
3. Castellone, M.D., et al. 2003. Ras-mediated apoptosis of PC CL 3 rat
thyroid cells induced by RET/PTC oncogenes. Oncogene 22: 246-255.
4. Davoodi-Semiromi, A., et al. 2004. A mutant Stat5β with weaker DNA
binding affinity defines a key defective pathway in nonobese diabetic
mice. J. Biol. Chem. 279: 11553-11561.
5. Weisleder, N., et al. 2004. Bcl-2 overexpression corrects mitochondrial
defects and ameliorates inherited desmin null cardiomyopathy. Proc.
Natl. Acad. Sci. USA 101: 769-774.
For research use only, not for use in diagnostic procedures.
See our web site at www.scbt.com or our catalog for detailed protocols
and support products.
Bcl-2 (N-19): sc-492
Santa Cruz Biotechnology, Inc.
1.800.457.3801 831.457.3800 fax 831.457.3801 Europe